BOSTON — A series of speakers here at this week’s IBC international protein arrays conference highlighted problems in working with the human plasma proteome, including a decline in success in finding proteins suitable for clinical diagnostic tests, a lack of validation following identification of potential biomarkers, and high costs for developing immunoassays.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.